Search - tctmd.com

Displaying 181 - 200 of 236

Sort: Relevancy | Date

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Presenter: John Ormiston

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

TCT 615: ABSORB EXTEND: An Interim Report on the 36-Month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

Presentation BRS 2014

BRS Capping of Vulnerable Plaque: PROSPECT ABSORB

Presenter: Gregg W. Stone

July 26, 2014

Presentation BRS 2014

Outcomes in Long Lesions and BRS Overlap (with Focus on Sidebranch Closure): ABSORB Extend

Presenter: Alexandre Abizaid

July 26, 2014

Presentation BRS 2014

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Presenter: P.C. Smits

July 26, 2014

Presentation BRS 2014

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Presenter: Roberto Diletti

July 25, 2014

Presentation BRS 2014

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Presenter: Richard J. Rapoza

July 25, 2014

Presentation BRS 2014

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

Presenter: Gregg W. Stone

July 25, 2014

Presentation BRS 2014

A Preview to ABSORB II

Presenter: Patrick W. Serruys

July 25, 2014

News Daily News

生物吸收支架表现良好，但是血栓形成引担忧

Todd Neale

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

Jason Kahn

February 20, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Presenter: Richard J. Rapoza

December 02, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Advertisement

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

TCT 615: ABSORB EXTEND: An Interim Report on the 36-Month Clinical Outcomes from the First 250 Patients Enrolled

BRS Capping of Vulnerable Plaque: PROSPECT ABSORB

Outcomes in Long Lesions and BRS Overlap (with Focus on Sidebranch Closure): ABSORB Extend

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

A Preview to ABSORB II

生物吸收支架表现良好，但是血栓形成引担忧

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content